Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

86.87
Delayed Data
As of Jul 06
 +0.83 / +0.96%
Today’s Change
31.99
Today|||52-Week Range
90.98
+103.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.00133.0K2.6M51.5M
 
 
 
 
Cost of Goods Sold0.00--1.0K1.1M
 
 
 
Depreciation And Amortization1.4M3.4M5.8M19.5M
 
 
 
 
 
 
Operating ExpensesGross Income-1.4M---3.2M30.8M
 
 
 
 
General Expenses146.4M244.7M319.7M402.2M
 
 
 
 
 
Research And Development114.7M183.2M231.6M294.0M
 
 
 
 
 
Total Operating Expenses147.7M248.1M325.6M422.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-147.7M-248.0M-322.9M-371.4M
 
 
 
 
 
Extraordinary Charge0.000.00-6.0M0.00
 
 
Other Expenses-200.0K-1.6M6.5M164.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-145.6M-245.8M-318.3M-197.1M
 
 
 
 
 
Income Taxes0.00-35.0K-16.2M-514.0K
 
 
 
 
Net Income-145.6M-245.9M-302.1M-197.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.8M39.6M42.5M49.8M
 
 
 
 
 
Shares To Calculate EPS Diluted36.8M39.6M42.5M49.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.96-$6.21-$7.12-$3.97
 
 
 
 
 
EPS Diluted-$3.96-$6.21-$7.12-$3.97